[Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs].
D000477:Alkylating Agents / Q000008:administration & dosage / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D008353:Mannitol / Q000031:analogs & derivatives*; D008927:Mitobronitol / Q000009:adverse effects*; D010198:Pancytopenia / Q000139:chemically induced; D011087:Polycythemia Vera / Q000188:drug therapy*
D000477:Alkylating Agents; D008353:Mannitol; D008927:Mitobronitol
Myelobromol (DBM) lökés-kezelés valódi polycythaemiában: tizenkét év tapasztalatai. Cytostaticum klinikai kipoóbálásának modellje.